News Image

ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of 2seventy bio, Inc.

Provided By PR Newswire

Last update: Mar 11, 2025

NEW YORK, March 11, 2025 /PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by 2seventy bio, Inc. (NASDAQ: TSVT) and its board of directors concerning the proposed acquisition of the company by Bristol Myers Squibb (NYSE: BMY). Stockholders will receive $5.00 for each share of 2seventy bio stock that they hold. The transaction is valued at approximately $286 million and is expected to close in the second quarter of 2025.

Read more at prnewswire.com